• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重产志贺毒素大肠埃希菌 O104:H4 感染后结肠并发症发生率低。

Low incidence of colonic complications after severe Shiga toxin-producing E. coli O104:H4 infection.

机构信息

I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Department of Anatomy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Z Gastroenterol. 2022 Jul;60(7):1104-1110. doi: 10.1055/a-1545-5322. Epub 2021 Nov 24.

DOI:10.1055/a-1545-5322
PMID:34820797
Abstract

BACKGROUND

In summer 2011, Shiga toxin producing Escherichia coli (EHEC) serotype O104:H4 caused the most severe EHEC outbreak in Germany to date. The case of a previously recovered patient with symptomatic postinflammatory colonic stenosis following EHEC- infection prompted us to conduct a prospective study to assess the macro- and microscopic intestinal long-term damage in a cohort of patients who had suffered from severe EHEC colitis.

METHODS

Following EHEC infection in 2011, 182 patients were offered to participate in this study between January 2013 and October 2014 as part of the post-inpatient follow-up care at the University Medical Center Hamburg-Eppendorf and to undergo colonoscopy with stepwise biopsies. Prior to colonoscopy, medical history and persistent post-infectious complaints were assessed.

RESULTS

Out of 182 patients, 22 (12%) participated in the study, 18 (82%) were female. All patients had been hospitalized due severe EHEC enterocolitis: 20 patients (90%) had subsequently developed hemolytic uremic syndrome (HUS), 16 patients (72%) had additionally required dialysis. On assessment prior to colonoscopy, all patients denied any abdominal complaints before EHEC-infection but 8 (36%) patients reported persistent post-infectious symptoms. According to the ROME IV criteria, 4 (18%) patients met the definition for post-infectious irritable bowel syndrome (PI-IBS). In all patients with persistent symptoms, colonoscopies and histological examination were unremarkable. Only in one symptom-free patient, biopsy revealed a locally limited cryptitis of the caecum, while all patients without complaints had inconspicuous histological and endoscopical findings.

CONCLUSION

Following infection colonic stenosis is a serious but rare long-term complication in patients who had suffered from severe enterocolitis. However, a significant proportion of these patients develop PI-IBS.

摘要

背景

2011 年夏季,产志贺毒素大肠埃希氏菌(EHEC)血清型 O104:H4 引发了德国迄今为止最严重的 EHEC 疫情。一位先前康复的 EHEC 感染后出现症状性炎症后结肠狭窄的患者促使我们进行了一项前瞻性研究,以评估一组曾患有严重 EHEC 结肠炎的患者的肠道宏观和微观长期损伤。

方法

在 2011 年 EHEC 感染后,182 名患者于 2013 年 1 月至 2014 年 10 月期间作为汉堡-埃彭多夫大学医学中心住院后随访的一部分,应邀参加了这项研究,并接受了结肠镜检查和逐步活检。在结肠镜检查前,评估了病史和持续性感染后投诉。

结果

在 182 名患者中,有 22 名(12%)参与了研究,其中 18 名(82%)为女性。所有患者均因严重 EHEC 肠炎住院:20 名患者(90%)随后发展为溶血尿毒综合征(HUS),16 名患者(72%)需要透析。在结肠镜检查前评估时,所有患者均否认在 EHEC 感染前有任何腹部不适,但 8 名(36%)患者报告有持续性感染后症状。根据罗马 IV 标准,4 名(18%)患者符合感染后肠易激综合征(PI-IBS)的定义。在所有持续性症状患者中,结肠镜检查和组织学检查均无异常。仅在一名无症状患者中,活检显示盲肠局部局限性隐窝炎,而所有无症状患者的组织学和内镜检查结果均无明显异常。

结论

感染后结肠狭窄是曾患有严重肠炎的患者的一种严重但罕见的长期并发症。然而,这些患者中有相当一部分会出现 PI-IBS。

相似文献

1
Low incidence of colonic complications after severe Shiga toxin-producing E. coli O104:H4 infection.严重产志贺毒素大肠埃希菌 O104:H4 感染后结肠并发症发生率低。
Z Gastroenterol. 2022 Jul;60(7):1104-1110. doi: 10.1055/a-1545-5322. Epub 2021 Nov 24.
2
Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.产志贺毒素 2 型大肠杆菌 O104:H4 感染患者的抗志贺毒素 2 型抗体可能预测溶血尿毒综合征。
J Gastroenterol Hepatol. 2018 Jul;33(7):1353-1356. doi: 10.1111/jgh.14082. Epub 2018 Mar 12.
3
Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4.2011 年肠出血性大肠杆菌 O104:H4 引起的小儿溶血尿毒综合征的中期随访。
Clin Infect Dis. 2017 Jun 15;64(12):1637-1643. doi: 10.1093/cid/cix218.
4
The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak-The Danger Is Still Out There.2011 年德国肠出血性大肠杆菌 O104:H4 暴发——危险仍然存在。
Curr Top Microbiol Immunol. 2018;416:117-148. doi: 10.1007/82_2018_107.
5
Escherichia coli O104:H4 Pathogenesis: an Enteroaggregative E. coli/Shiga Toxin-Producing E. coli Explosive Cocktail of High Virulence.产志贺毒素大肠埃希氏菌/肠聚集性大肠埃希氏菌引发的 O104:H4 大肠杆菌的发病机制:高毒性的爆炸性鸡尾酒。
Microbiol Spectr. 2014 Dec;2(6). doi: 10.1128/microbiolspec.EHEC-0008-2013.
6
Pro-inflammatory capacity of Escherichia coli O104:H4 outbreak strain during colonization of intestinal epithelial cells from human and cattle.产肠毒素大肠埃希氏菌 O104:H4 暴发菌株在人源和牛源肠上皮细胞定植过程中的促炎能力。
Int J Med Microbiol. 2018 Oct;308(7):899-911. doi: 10.1016/j.ijmm.2018.06.003. Epub 2018 Jun 19.
7
Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study.住院患者肠出血性大肠杆菌 O104 感染的症状和临床过程:一项前瞻性单中心研究。
PLoS One. 2013;8(2):e55278. doi: 10.1371/journal.pone.0055278. Epub 2013 Feb 27.
8
Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.德国产志贺毒素大肠杆菌 O104:H4 疫情概况。
N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.
9
Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.采用快速下一代测序技术对德国肠出血性大肠杆菌 O104:H4 暴发进行前瞻性基因组特征分析。
PLoS One. 2011;6(7):e22751. doi: 10.1371/journal.pone.0022751. Epub 2011 Jul 20.
10
The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.2011 年德国北部肠出血性大肠杆菌血清型 O104:H4 暴发期间成人的神经综合征。
Brain. 2012 Jun;135(Pt 6):1850-9. doi: 10.1093/brain/aws090. Epub 2012 Apr 26.

引用本文的文献

1
Isolation and identification of bacteriophage against Escherichia coli ATCC 25922 and their biofilm Inhibition studies.抗大肠杆菌ATCC 25922噬菌体的分离鉴定及其生物膜抑制研究。
Sci Rep. 2025 Jul 24;15(1):26964. doi: 10.1038/s41598-025-12366-z.